| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 304 5 |
| Ultima descărcare din IBN: 2023-10-20 10:49 |
| Căutarea după subiecte similare conform CZU |
| 616.857-085.216.84 (2) |
| Neurology. Neuropathology. Nervous system (985) |
 SM ISO690:2012SCERBATIUC, Cristina, BENDELIC, Eugeniu, JERU, Ion. Utilizarea colirului oftalmic Timolol 0,5% în profilaxia atacurilor migrenoase. In: Sănătate Publică, Economie şi Management în Medicină , 2022, nr. 1(92-S), p. 43. ISSN 1729-8687. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Sănătate Publică, Economie şi Management în Medicină | |||||||
| Numărul 1(92-S) / 2022 / ISSN 1729-8687 /ISSNe 2587-3873 | |||||||
|
|||||||
| CZU: 616.857-085.216.84 | |||||||
| Pag. 43-43 | |||||||
|
|||||||
 Descarcă PDF |
|||||||
| Rezumat | |||||||
Migraine is often associated with photophobia, phonophobia, dizziness, sometimes vomiting, and fatigue. The aim of the study was to study the effectiveness of the 0.5% Timolol solution in migraine attacks. Cases of complete resolution of ophthalmoplegia and visual field deficiency in patients with hemiplegic migraine are reported in the literature. This method of treatment may be effective in preventing migraine attacks, determining ophthalmic features in patients with migraine, and studying the correlation between the presence of retrobulbar pain in migraine attacks and the value of intraocular pressure. |
|||||||
| Cuvinte-cheie migraine, autonomic nervous system, beta-blocker, Timolol, migrena, sistem nervos autonom, beta-blocant, timolol |
|||||||
|
|
|
|
